Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Farmacan AS
AS
Active
Org 826135182
Sandsdalens Gate 2, 3683
Notodden
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2020 · 5 years old
2 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Farmacan AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 3M (+200% vs 2021)
3M
+200%
2022
2023: 1M (-67% vs 2022)
1M
-67%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
Revenue
889
1 371
2 694
1 179
Staff expenses
−0
−353
−430
−391
EBITDA
−233
−248
263
65
Depreciation & amort.
−56
−56
−0
−0
EBIT
−290
−304
263
65
Net financials
0
0
28
1
Profit before tax
−290
−304
291
66
Tax
−0
−0
64
15
Net profit
−290
−304
227
52
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
Total assets
525
1 591
1 421
1 046
Equity
−265
25
303
82
Long-term debt
0
0
0
0
Short-term debt
790
1 566
1 118
965
Total debt
790
1 566
1 118
965
Financial ratios
5-year trend
EBITDA margin
−26,3 %
This company
15,8 %
Market median
This company
Market median
266% below market
2021
2024
Equity ratio
−50,4 %
This company
38,2 %
Market median
This company
Market median
232% below market
2021
2024
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2024
Net profit margin
−32,6 %
This company
8,1 %
Market median
This company
Market median
502% below market
2021
2024
Asset turnover
1,69×
This company
1,12×
Market median
This company
Market median
51% above market
2021
2024
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-11-03 – 2021-12-31
View
PDF
More on Farmacan AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
